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Objective: Little is known about recurrent risk profile of brain infarct (BI) in Japan. The study 
aimed to clarify clinicoradiological features of recurrent BI patients.
Methods: 374 consecutive BI patients (231 men and 143 women) were admitted to our 
  department between 2007 and 2008. Recurrent BI was defined as a prior history of BI. 
  Cardiovascular disease (CVD) risk profile, stroke mechanism subtypes and Bamford subtypes 
were compared between the first BI and the recurrent BI group. CVD risk factors, stroke subtypes 
of the first BI and preventative medication were analyzed in recurrent BI patients.
Results: Recurrent BI existed in 72 patients (40 men and 32 women). Age of the recurrent 
BI group was significantly older than the first BI group (P , 0.01). In comparison to the first 
BI group, the recurrent BI group had a high frequency of hypertension (P , 0.01) and CVD 
comorbidity (P , 0.05). Recurrent rates were increased significantly in cardioembolic patients 
as compared to the first BI patients (P , 0.05). Bamford BI subtypes did not differ between 
both groups. Mean recurrent interval (SD) was 3.1 (2.3) years. Approximately half the patients 
experienced recurrent BI less than 2 years after the first BI. Antiplatelet agents were used in 
33 patients and warfarin was used in 12 patients as preventative medication. The remaining 
27 patients had no prevention therapy by self-cessation. Nine warfarin users were controlled 
poorly. There were no significant correlations between the first and recurrent Bamford subtypes 
in recurrent BI patients.
Conclusions: The present study indicated that the recurrent frequency of BI was 19.3%. Caus-
ative profile of recurrent BI suggested elderly age ($65 years), hypertension, prior history of 
CVD, cardioembolism, 2 years poststroke, insufficient treatment of warfarin and self-cessation 
of preventative medication. Thus, physicians should pay more attention to these aspects for 
prophylaxis of recurrent BI in poststroke patients.
Keywords: brain infarct, recurrence, cardiovascular disease risk profile, secondary 
prevention
Introduction
Recurrent stroke is an important cerebrovascular event affecting the life of survivors 
of ischemic stroke.1 The second stroke event is an important predictor of functional 
outcomes as well as mortality after the first stroke.2,3 Together with therapeutic devel-
opment of acute brain infarcts (BI), secondary prevention of BI is always required in 
patients with the first BI event. Many prospective studies of recurrent stroke have been 
reported previously in European and North American populations.1–10 Asian prospec-
tive studies suggested clinicoradiological hallmarks of recurrent BI.11–14 The present 
retrospective study aimed to elucidate cardiovascular disease (CVD) risk factors and 
neuroradiological features of recurrent BI in Japanese BI patients. We attempted Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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to confirm the importance of preventative healthcare for 
  poststroke patients.
Methods
Bi patients
390 consecutive patients (241 men and 149 women) were 
diagnosed as BI and admitted to our department between Janu-
ary 2007 and December 2008. Mean age (SD) was 69.6 (12.1) 
years [67.6 (12.5) in men and 73.0 (10.7) years in women]. We 
reviewed medical and neuroradiological records. All patients 
had acute BI within 1 week of clinical onset. BI patients who 
did not undergo magnetic resonance imaging (MRI) and 
angiography (MRA) were excluded from the present study. 
The present study was approved by ethical committee of Toho 
University Omori Medical Center.
Brain Mri and MrA
Brain MRI and MRA were performed by a 1.5-tesla super-
conducting system. Axial T1-weighted imaging, T2-weighted 
imaging, fluid-attenuated inversion imaging and diffusion-
weighted imaging (DWI) were obtained. A slice/gap thickness 
of MRI was 6.0/0.5 mm and the matrix size was 224 × 256 for 
all sequences. The number of acquisitions was 2. MRA was 
applied by 3-dimensional time-of-flight technique. A slice 
thickness was 0.6 mm and the matrix size was 256 × 256 on 
MRA. Experienced neuroradiologists reviewed brain MRI 
and MRA. Acute BI lesions were defined as hyperintensity 
signal areas on DWI and the subsequent new hyperintensity 
signal areas on T2-weighted imaging.
Diagnosis and preventative medication 
of recurrent Bi
Among the patients fulfilling the MRI definition mentioned 
above, recurrent BI was defined as obvious prior history of BI 
events. The interval between the first and the second BI was 
assessed. Use of antiplatelet and anticoagulant agents was 
analyzed in recurrent BI patients. International ratio (INR) of 
prothrombin time was evaluated in warfarin-treated patients.
cVD risk factors
CVD risk factors were analyzed on the following 7 items:
•	 obesity (body mass index $ 25.0 kg/m2);
•	 current smoker;
•	 hypertension (systolic blood pressure $ 140 mmHg or 
diastolic blood pressure $ 90 mmHg) or currently under 
treatment;
•	 diabetes mellitus [(DM) fasting blood sugar $ 126 mg/dL or 
hemoglobin A1c $ 6.5%] or currently under treatment;
•	 dyslipidemia  (serum  low-density  lipoprotein 
  cholesterol $140 mg/dL or high-density lipoprotein 
  cholesterol ,40 mg/dL) or currently under treatment;
•	 chronic or paroxysmal atrial fibrillation (AF);
•	 prior history of CVD.
CVD was defined as ischemic heart diseases,   including 
myocardial infarction and angina pectoris. CVD risk pro-
file was compared between the first and the recurrent BI 
group.
neuroradiological assessment
Stroke mechanism subtype was divided into lacunar infarct 
(LACI), cardioembolism, atherothrombosis and other. BI 
topography was classified to four categories according to 
Bamford subtypes.15 LACI; total anterior circulation infarct 
(TACI); partial anterior circulation infarct (PACI); posterior 
circulation infarct (POCI). Frequency of stroke mechanism 
subtype and Bamford subtypes was compared between the 
first and the recurrent BI group. In recurrent BI patients, 
stroke mechanism subtype and Bamford subtype of the first 
BI were analyzed by a medical history and MRI findings.
statistical analysis
Statistical analyses of CVD risk factors and   neuroradiological 
data used unpaired Student’s T-test, χ2 test and one-way anal-
ysis of variance. All significance levels were set at 0.05.
Results
Frequency of recurrent Bi
Among 390 patients, 16 patients (10 men and 6 women) 
excluded, as brain MRI and MRA were not undergone. 
Recurrent BI existed in 72 patients (40 men and 32 women). 
Four patients (2 men and 2 women) had 3 BI events. Fre-
quency of recurrent BI was 19.3%, 17.3% in men and 22.4% 
in women. There were no significant differences of sex 
between the first and recurrent BI patients (Table 1).
CVD risk profile of recurrent 
Bi patients
Frequency of CVD risk factors is listed in Table 1. Mean 
age (SD) of the recurrent BI group was 74.5 (9.8) years 
[72.0 (9.8) in men and 77.7 (9.0) in women]. The age of 
the first BI group was 68.4 (12.3) years [64.7 (13.3) in 
men and 74.7 (6.9) in women]. The age of the recurrent BI 
group was significantly older than that of the first BI group 
(P , 0.01). The frequency of elderly patients ($65 years) 
was increased in the recurrent BI group, in comparison 
with the first BI group (P , 0.01). In comparison to the Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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first BI group, hypertension rates were significantly higher 
in the recurrent BI group (P , 0.01). Frequency of prior 
CVD history was significantly increased in the recurrent 
BI group more than the first BI group (P , 0.05). Other 
CVD risk factors did not differ between the first and the 
recurrent BI group.
interval and preventative medicine 
of recurrent Bi
Mean interval (SD) between the first and the recurrent 
BI was 3.1 (2.3) years. Approximately half the patients 
(52.8%) experienced recurrent BI within 2 years from pre-
vious BI. Of 72 recurrent patients, 33 patients received anti-
platelet agents: 19 patients aspirin; 11 patients cilostazol; 
3 patients clopidogrel. Warfarin was used in 12 patients. 
The remaining 27 patients had no preventative medication 
by self-cessation (Table 2). Chronic AF or prior history 
of CVD existed in 10 antiplatelet users and 12 warfarin 
users. Mean INR (SD) was 1.5 (0.3) and INR was less than 
1.4 in 9 warfarin users. A total of 36 patients disclosed 
self-cessation of antiplatelet agents or uncontrolled war-
farin medication.
stroke mechanism and Bamford  
subtypes of the first and recurrent BI
There were no significant differences in stroke mechanism 
and Bamford subtypes between the first and the recurrent 
BI group (Table 3). The first BI subtypes of recurrent 
patients are expressed in Table 2. The most common 
subtype of the first BI was cardioembolism on stroke 
mechanism and LACI on Bamford subtype. Recurrent rates 
were increased significantly in cardioembolic patients as 
compared to the first BI patients (P , 0.05). As compared 
to the first BI patients, significant differences of CVD 
profile were not found in recurrent cardioembolic patients 
and LACI patients.
Discussion
Our retrospective study indicated that the frequency of 
  recurrent BI was 19.3%, 17.3% in men and 22.4% in women. 
Approximately half of recurrent BI occurred within 2 years 
post-BI. Recurrent BI profiles revealed elderly patients, 
hypertension, prior history of CVD, cardioembolism, uncon-
trolled preventative medication.
Predictors of recurrent stroke have been reported previ-
ously in many prospective studies.1–14 The risk of a recurrent 
cerebrovascular event is highest in the first month and year 
after a stroke and transient ischemic attack (TIA). Approximate 
12% of patients have a recurrent stroke within the first year 
Table 1 CVD risk profile in the first and recurrent B1 group
First BI group (n =	302) Recurrent BI group (n =	72) All patients (n =	374)
Men/women 191/111 40/32 231/143
Mean age (sD) years 68.4 (12.3) 74.5 (9.8)** 69.6 (12.1)
Hypertension 186 (61.6%) 56 (77.8%)** 242 (64.7%)
Obesity 69 (22.8%) 20 (27.8%) 89 (23.8%)
Dyslipidemia 71 (23.5%) 19 (26.4%) 90 (24.1%)
smoking history 175 (57.9%) 32 (44.4%) 207 (55.3%)
Diabetes mellitus 92 (30.5%) 22 (30.6%) 114 (30.5%)
Atrial fibrillation 66 (21.9%) 23 (31.9%) 89 (23.8%)
Prior history of cVD 76 (25.2%) 27 (37.5%)* 103 (27.5%)
Notes: *P , 0.05; **P , 0.01 between the first and the recurrent BI group.
Abbreviations: cVD, cardiovascular disease; Bi, brain infarct.
Table  2  Interval  time,  preventative  medication  and  the  first 
stroke subtypes in recurrent Bi patients
Recurrent BI (n =	72)
Mean interval (sD) 3.1 (2.3) years
 # 1 year 22 (30.6%)
  1–2 years 16 (22.2%)
 $ 2 years 34 (47.2%)
Preventative medication
  Antiplatelet agents 33 (45.8%)
    Aspirin 19 (26.4%)
    cilostazol 11 (15.3%)
    clopidogrel 3 (4.2%)
  Warfarin 12 (16.7%)
  self-cessation 27 (37.5%)
Stroke mechanism subtypes 
of the first BI
  LAci 25 (34.7%)
  cardioembolism 42 (58.4.%)*
  Atherothrombosis 1 (1.3%)
  Others 4 (5.6%)
Bamford subtypes of the first BI
  LAci 25 (34.7%)
  TAci 13 (18.1%)
  PAci 20 (27.8%)
  POci 14 (19.4%)
Note: *P , 0.05 between the first and the recurrent BI group. 
Abbreviations:  Bi,  Brain  infarct;  LAci,  lacunar  infarct;  TAci,  total  anterior 
circulation  infarct;  PAci,  partial  anterior  circulation  infarct;  POci,  posterior 
circulation infarct.Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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Other clinical predictive factors of embolic BI recurrence 
in cardioembolic stroke patients exhibited alcohol abuse, 
hypertension, valvular heart disease and AF.16 Hypertension 
and DM were shown as significant factors of recurrent LACI 
in 733 consecutive patients with LACI.17 We also compared 
CVD risk factors in the first and the recurrent patients with 
cardioembolic infarct or LACI. There were no statistical 
differences of CVD profile in our recurrent cardioembolism 
or LACI patients. Besides CVD risk factors and stroke sub-
type, 27 recurrent patients stopped preventative therapy by 
themselves in the present study. Half the recurrent BI patients 
received no satisfactory prophylactic medication. Thus, phy-
sicians should give strict informed consent of preventative 
medication to BI patients.
Conclusion
The present study indicated that recurrent rates of BI were 
not uncommon in Japanese poststroke patients. Clinical 
hallmarks of recurrent BI patients suggested older age, hyper-
tension, CVD events, cardioembolic infarct, recent 2 years 
post-BI, uncontrolled warfarin treatment and self-cessation of 
medication. Thus, we emphasize that physicians should pay 
more attention to those high-risk aspects of recurrent BI.
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and 30% experience recurrence over 5 years.5,6 In Rochester, 
Minnesota, the major predictor was DM.7,8 In the Northern 
Manhattan Stroke Study, baseline predictors of recurrent stroke 
were high alcohol consumption, hypertension at discharge and 
blood glucose concentration at hospital admission.9 The Perth 
Community Stroke Study also found older age, 75–84 years 
and DM to be major predictors of recurrent stroke at 5 years.6 
Baseline predictors of stroke recurrence in the Malmö Stroke 
Registry were DM, TIA and AF.10 Several Asian studies also 
described recurrent rate and CVD profile in BI patients.11–14 
Recurrence of ischemic stroke was associated with male 
patients, hyperlipidemia, AF and smoking in Taiwanese case-
control study. Frequency of LACI was significantly lower in 
recurrent BI than initial BI.11 Among 8,036 BI hospitalized 
patients, 395 patients (4.9%) developed a recurrent stroke 
within 30 days at poststroke. Recurrence most frequently 
occurred in atherothrombotic patients (6.6%), followed by 
cardioembolic patients (6.2%). A previous study confirmed 
that hypertension and AF contribute to early ischemic stroke 
recurrence in Japanese BI patients.12 A Chinese cohort study 
revealed first-year recurrence rate of 11.2% in the registered 
BI patients. Hypertension, AF and smoking were associ-
ated with increased risk of BI recurrence.13 Among 1,732 
consecutive patients with first-ever acute stroke, including 
atherothrombotic infarction, LACI, cardioembolic infarction, 
other infarction, and brain hemorrhage, the overall recurrence 
rate within the first year was 6.5%. Patients with cardioembo-
lic infarction (9.0%) and other type of infarction (9.1%) had 
more recurrent strokes within the initial year compared with 
the other subtypes. AF, ischemic heart disease, history of TIA 
and disability at discharge were important determinants for 
stroke recurrence and death.14 Therefore, clinical profile of 
recurrent BI identified the similarity between our study and 
previous Asian studies.11–14Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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